Cellegy Announces Third Quarter Results.FOSTER CITY, Calif.--(BUSINESS WIRE)--Nov. 4, 1996--Cellegy Pharmaceuticals Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :CLGY, Warrants:CLGYW) today announced that for the third quarter ended Sept. 30, 1996, the company had a net loss of $894,000, or $0.20 per share, compared with a net loss of $884,000, or $0.27 per share, for the same period last year. For the nine months ended Sept. 30, 1996, the company had a net loss of $2,750,000, or $0.68 per share, on revenues of $15,000, compared with a net loss of $1,243,000, or $0.41 per share, on revenues of $1,000,000, for the nine months ended Sept. 30, 1995. Revenues in 1995 resulted from the company's licensing arrangement with Neutrogena Please help [ rewrite this article] from a neutral point of view. Mark blatant advertising for , using . Corp., a subsidiary of Johnson & Johnson. Cash, cash equivalents and short-term Short-term Any investments with a maturity of one year or less. short-term 1. Of or relating to a gain or loss on the value of an asset that has been held less than a specified period of time. investments at Sept. 30, 1996, were approximately ap·prox·i·mate adj. 1. Almost exact or correct: the approximate time of the accident. 2. $7.5 million. On Oct. 17, 1996, the company announced that it had signed a Letter of Intent with Glaxo Wellcome This article is about the supermarket chain. For the pharmaceutical entrepreneur, see Henry Wellcome. For the charity and related companies, see Wellcome Trust. Wellcome (Chinese: 惠康 Inc. for the licensing of Glylorin(TM). Cellegy is in the process of finalizing the definitive agreement, which it believes will strengthen the company's cash position, lower its research and development costs associated with Glylorin development funding, which will be assumed by Glaxo, and result in certain near term contract revenues. Cellegy is currently in active discussions with a number of other potential corporate partners for the development and licensing of its products. Although there can be no assurance that these discussions will result in definitive agreements, these partnerships, once completed, could be a potential source of significant future revenue. Cellegy is a pharmaceutical company engaged in the development, through corporate collaborations and marketing arrangements, of innovative drug delivery products as well as consumer and prescription prescription In property law, the effect of the lapse of time in creating and destroying rights. Acquisitive prescription allows an individual, after unequivocal possession for a specific period, to acquire an interest in real property, such as an easement, but not the products for the skin. -0-
Cellegy Pharmaceuticals Inc.
Summary Financial Results
Condensed Statements of Operations
(Amounts in Thousands, except per share amounts)
Three Months Ended Nine Months Ended
Sept. 30, Sept. 30,
1996 1995 1996 1995
Revenues $ --- $ --- $ 15 $ 1,000
Operating and other income
(expenses) $ (894) $ (884) $(2,765) $(2,243)
Net income (loss) $ (894) $ (884) $(2,750) $(1,243)
Net income (loss) per
share $ (0.20) $ (0.27) $ (0.68) $ (0.41)
Condensed Balance Sheets
(Amounts in thousands)
Sept. 30, 1996 Dec. 31, 1995
Cash, cash equivalents & short term
investments $7,505 $3,820
Other assets $ 356 $ 208
Total Assets $7,861 $4,028
Payables and accrued liabilities $ 160 $ 380
Shareholders' equity $7,701 $3,648
Total liabilities and shareholders'
equity $7,861 $4,028
CONTACT: Cellegy Pharmaceuticals Inc. A. Richard Ri·chard , Joseph Henri Maurice Known as "Rocket." 1921-2000. Canadian hockey player. A right wing for the Montreal Canadiens (1942-1960), he led his team to eight Stanley Cup championships and was the first player to score 50 goals in a Juelis, 415/524/1600 (company) or Jimmy Caplan Caplan may refer to:
or Rick Eisenberg Eisenberg can refer to:
|
|
||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion